CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Ramipril/hydrochlorothiazide

Last Updated: October 26, 2006
Result type: Reports
Project Number: S0083
Product Line: Common Drug Review

Generic Name: Ramipril/hydrochlorothiazide

Brand Name: Altace HCT

Manufacturer: Sanofi –Aventis Canada inc.

Indications: Hypertension

Submission Type: New

Project Status: Cancelled